DIANA HAUSMAN

Insider Reports History

Location
Seattle, WA
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DIANA HAUSMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 373,876 $4,718,315 $12.62 09 May 2024 Direct
Immuneering Corp Director Class A Common Stock 3,000 $10,873 $3.62 02 Jul 2025 By spouse
Immuneering Corp Director Class A Common Stock 2,500 $8,989 $3.60 02 Jul 2025 Direct
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 337,500 01 Feb 2024 Direct
Immuneering Corp Director Stock Option 33,350 13 Jun 2025 Direct

Insider Reports Filed by DIANA HAUSMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMRX Immuneering Corp 02 Jul 2025 2 +$19,862 4 Director 07 Jul 2025, 08:59
IMRX Immuneering Corp 13 Jun 2025 1 $0 4 Director 16 Jun 2025, 09:21
IMRX Immuneering Corp 12 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:16
ZNTL Zentalis Pharmaceuticals, Inc. 09 May 2024 1 -$42,353 4 Chief Medical Officer 09 May 2024, 19:46
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2024 2 $0 4 Chief Medical Officer 05 Feb 2024, 19:16
IMRX Immuneering Corp 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:39
ZNTL Zentalis Pharmaceuticals, Inc. 08 May 2023 1 $0 4 Director 10 May 2023, 07:13
ZNTL Zentalis Pharmaceuticals, Inc. 08 May 2023 0 $0 3 Director 10 May 2023, 07:11
IMRX Immuneering Corp 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:56
IMRX Immuneering Corp 14 Jan 2022 1 +$327,600 4 Director 18 Jan 2022, 07:21
IMRX Immuneering Corp 14 Jan 2022 0 $0 3 Director 18 Jan 2022, 07:19